Qube Research & Technologies LTD Evotec Se Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Evotec Se stock. As of the latest transaction made, Qube Research & Technologies LTD holds 59 shares of EVO stock, worth $270. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59
Previous 717
91.77%
Holding current value
$270
Previous $5,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EVO
# of Institutions
32Shares Held
2.86MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA2.03MShares$9.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny192KShares$877,1980.0% of portfolio
-
Mediolanum International Funds LTD Dublin 1, L2140KShares$642,9540.01% of portfolio
-
Morgan Stanley New York, NY122KShares$557,8890.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT115KShares$526,4840.3% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.62B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...